Quarterly report pursuant to Section 13 or 15(d)

Schedule of Segment Information (Details)

v3.22.2
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Segment Reporting Information [Line Items]          
Consolidated net revenue $ 29,092 $ 9,142 $ 76,623 $ 24,413  
Consolidated cost of revenue 10,372 4,676 29,226 11,020  
Total Depreciation and amortization expense 1,195 395 2,371 743  
Operating and other expenses 7,114 5,466 18,705 12,988  
Total income (loss) from operations, after income taxes 7,446 (1,395) 19,940 (338)  
Total income from operations, before income taxes 10,411 (1,395) 26,321 (338)  
Income tax expense (2,965) (6,381)  
Net income (loss) 7,446 (1,395) 19,940 (338)  
Total assets 97,947   97,947   $ 89,295
Diagnostic Services [Member]          
Segment Reporting Information [Line Items]          
Consolidated net revenue 26,158 7,537 71,071 20,274  
Consolidated cost of revenue 8,403 3,479 25,105 7,824  
Total Depreciation and amortization expense 594 392 1,170 737  
Total income (loss) from operations, after income taxes 12,872 1,164 32,898 4,004  
Total assets 49,493   49,493   51,150
Consumer Products [Member]          
Segment Reporting Information [Line Items]          
Consolidated net revenue 2,934 1,605 5,552 4,139  
Consolidated cost of revenue 1,969 1,197 4,121 3,196  
Total Depreciation and amortization expense 601 3 1,201 6  
Total income (loss) from operations, after income taxes (313) 540 (2,176) 505  
Total assets 23,027   23,027   24,139
Unallocated Corporate [Member]          
Segment Reporting Information [Line Items]          
Total income (loss) from operations, after income taxes (2,148) $ (3,099) (4,401) $ (4,847)  
Total assets $ 25,427   $ 25,427   $ 14,006